Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
NCT02396342
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia B
Interventions
GENETIC:
AAV5-hFIX
Sponsor
CSL Behring